---
aliases: >-
  /news/brain-computer-interface-company-precision-neuroscience-scores-41m-and-more-digital-health-fundings
archetype: curated-content
author:
  - Athira Ravi
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - >-
    Brain-computer interface company Precision Neuroscience scores $41M and more
    digital health fundings
categories:
  - 'The Healthcare Guys: Digital Health Funding'
  - 'Gartner: Healthcare'
categorySlug:
  - 'the healthcare guys: digital health funding'
  - 'gartner: healthcare'
categoryUrl:
  - topic/the-healthcare-guys-digital-health-funding
  - topic/gartner-healthcare
categoryLabel:
  - Digital Health Funding
  - Healthcare
contentCategories: netspective-medigy-news-curated-content
institution: null
offering: null
layOut: single
date: '2023-01-28'
description: >-
  AI-based drug discovery platform Atomic AI, senior lifestyle company Mighty
  Health, Lithuania-based Oxipit and cybersecurity firm MedCrypt also closed
  funding rounds. Precision Neuroscience Corporatio
favIconImage: null
featuredImage:
  alt: >-
    Brain-computer interface company Precision Neuroscience scores $41M and more
    digital health fundings
  format: JPEG
  href: b86c46e1-f88c-52cb-82c7-60bd701388b5-featuredImage.jpeg
  size:
    - 630
    - 1200
  valid: true
  workPackage: 16811
  wpAttachment:
    fileName: Curated_Featured_Image.jpeg
    link: /api/v3/attachments/30485/content
featuredPdf: null
htmlMetaData:
  author: null
  description: null
  generator: null
  viewport: null
  articlemodified_time: null
  articlepublished_time: null
  msvalidate.01: null
  ogdescription: >-
    AI-based drug discovery platform Atomic AI, senior lifestyle company Mighty
    Health, Lithuania-based Oxipit and cybersecurity firm MedCrypt also closed
    funding rounds.
  ogimage: null
  ogsite_name: null
  ogtitle: >-
    Brain-computer interface company Precision Neuroscience scores $41M and more
    digital health fundings
  ogtype: null
  ogupdated_time: null
  ogurl: null
  yandex-verification: null
  robots: null
  fbapp_id: null
  oglocale: null
  fbadmins: null
  articlepublisher: null
  google-site-verification: null
  keywords: null
id: 16811
identifier: News
lastMod: '2023-01-28T08:19:26.962937Z'
link:
  brand: mobihealthnews.com
  href: >-
    https://www.mobihealthnews.com/news/brain-computer-interface-company-precision-neuroscience-scores-41m-and-more-digital-health
  original: >-
    https://www.mobihealthnews.com/news/brain-computer-interface-company-precision-neuroscience-scores-41m-and-more-digital-health
href: >-
  https://www.mobihealthnews.com/news/brain-computer-interface-company-precision-neuroscience-scores-41m-and-more-digital-health
original: >-
  https://www.mobihealthnews.com/news/brain-computer-interface-company-precision-neuroscience-scores-41m-and-more-digital-health
mastHead: NEWS
mdName: b86c46e1-f88c-52cb-82c7-60bd701388b5.md
openGraphMetaData:
  ogdescription: >-
    AI-based drug discovery platform Atomic AI, senior lifestyle company Mighty
    Health, Lithuania-based Oxipit and cybersecurity firm MedCrypt also closed
    funding rounds.
  ogtitle: >-
    Brain-computer interface company Precision Neuroscience scores $41M and more
    digital health fundings
  ogurl: null
  ogimage: null
  ogsite_name: null
  ogtype: null
  ogupdated_time: null
  ogimageheight: null
openProjectCustomFields:
  cleanUrl: >-
    https://www.mobihealthnews.com/news/brain-computer-interface-company-precision-neuroscience-scores-41m-and-more-digital-health
  medigyTopics:
    - 'The Healthcare Guys: Digital Health Funding'
    - 'Gartner: Healthcare'
  sourceUrl: >-
    https://www.mobihealthnews.com/news/brain-computer-interface-company-precision-neuroscience-scores-41m-and-more-digital-health
openProjectWorkPackageType: Curated Content
searchCategory: News
slug: >-
  mobihealthnews-brain-computer-interface-company-precision-neuroscience-scores-41m-and-more-digital-health-fundings
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: >-
  Brain-computer interface company Precision Neuroscience scores $41M and more
  digital health fundings
via: ' '
insights_description: ''
insights_name: ''
viaLink: null
relatedOfferings:
  - label: Emulait Starter Kit
    permalink: /offering/emulait-starter-kit
    categories:
      - 'Gartner: Healthcare'
    offeringId: 17281
  - label: DeepIntent Platform
    permalink: /offering/deepintent-platform
    categories:
      - 'Gartner: Healthcare'
    offeringId: 17259
  - label: Medix Healthcare
    permalink: /offering/medix-healthcare
    categories:
      - 'Gartner: Healthcare'
      - 'KLAS: Scheduling - Nurse and Staff'
    offeringId: 16888
  - label: Spect's enterprise solution
    permalink: /offering/spects-enterprise-solution
    categories:
      - 'Gartner: Healthcare'
    offeringId: 16087
  - label: Salvo Health Platform
    permalink: /offering/salvo-health-platform
    categories:
      - 'Gartner: Healthcare'
      - 'Symplur: Virtual Care'
    offeringId: 16063
twitterMetaData:
  twittercard: null
  twitterdescription: >-
    AI-based drug discovery platform Atomic AI, senior lifestyle company Mighty
    Health, Lithuania-based Oxipit and cybersecurity firm MedCrypt also closed
    funding rounds.
  twittertitle: >-
    Brain-computer interface company Precision Neuroscience scores $41M and more
    digital health fundings
  twitterimage: null
  twitterurl: null
---
<p>AI-based drug discovery platform Atomic AI, senior lifestyle company Mighty Health, Lithuania-based Oxipit and cybersecurity firm MedCrypt also closed funding rounds. Precision Neuroscience Corporation, a brain-computer interface business based in New York, completed a $41 million Series B investment round, increasing its total funding raised to $53 million. With participation from Alumni Ventures, Draper Associates, Mubadala Capital, and re.Mind Capital, Forepont Capital Partners led the round. Steadview Capital and B Capital Group, who are already investors, also contributed. The money will be used by Precision to grow its staff and advance product development. In the upcoming months, the company intends to request FDA regulatory scrutiny. In a statement, Precision Neuroscience CEO Michael Mager stated, "We foresee a world where catastrophic neurological disorders - stroke, traumatic brain injury, dementia are ultimately treated." "Brain-computer interface technology must advance from the lab and into the clinic in order to be used in this world.</p>